Back to UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

FATEFATE
Showing 4 of 26 quarters

Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCUBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in FATE THERAPEUTICS INC

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 815 shares of FATE (FATE THERAPEUTICS INC), worth $2,201 as of 2026-Q2.

Current Value

$2,201

Current Shares

815

Total Value Change

-$495,258

Total Shares Change

-141,316

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
815
0.0%
$2,2010.0%$2.70
0
2026-Q1
New
815
-
$9780.0%$1.37
17
2024-Q4
Exited
0
-100.0%
$00.0%$1.62
0
2024-Q3
Decreased
142,131
-24.6%
$497,4590.0%$3.57
0

Other major holders of FATE: BNP PARIBAS FINANCIAL MARKETS, ARK Investment Management LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used